Status:
UNKNOWN
The Therapeutic Effect of Catgut Embedding in Obesity
Lead Sponsor:
Taipei City Hospital
Collaborating Sponsors:
National Yang Ming Chiao Tung University
Conditions:
Obese Women
Eligibility:
FEMALE
20-65 years
Phase:
PHASE4
Brief Summary
The aim of this double-blind, randomized, placebo-controlled trial is to evaluate the therapeutic effects of acupoint stimulation by catgut embedding on complexion, quality of life, lipid profile, inf...
Detailed Description
We will recruit 90 females aged from 16 year-old to 65 year-old with body mass index(BMI) 27㎞/㎡ and waist circumference≧80cm. After inform consent, they will be randomly assigned into two groups. In g...
Eligibility Criteria
Inclusion
- body mass index (BMI) ≥ 27 kg/m2 waist circumference (WC) ≥ 80 cm and willing to participate in and fill out the questionnaires for this trial.
Exclusion
- Endocrine disease(Thyroid disease, pituitary disease, diabetes mellitus) Autoimmune disease(SLE、SSS、RA) Heart disease(Heart failure, arrhythmia etc.) Abnormal liver function(GOT\>80U/L、GPT\>80U/L) Abnormal kidney function(serum creatinine\>2.5 mg/dL) Stroke disease in past one year Under breast feeding or pregnancy Coagulation disorder Subjects with keloid disorder Accept weight reduction treatment in last two months
Key Trial Info
Start Date :
January 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2014
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT02276235
Start Date
January 1 2014
End Date
December 1 2014
Last Update
October 28 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Branch of Chinese Medicine, Taipei City Hospital
Taipei, Taiwan, Taiwan, 886